Technology Ownership Clause Samples
The Technology Ownership clause defines who holds the rights to any technology, inventions, or intellectual property developed or used under the agreement. Typically, it specifies whether ownership remains with the original creator, is transferred to the client, or is shared between parties, and may address both pre-existing and newly developed technologies. This clause is essential for preventing disputes over intellectual property by clearly allocating ownership and usage rights, ensuring all parties understand their entitlements and obligations regarding the technology involved.
POPULAR SAMPLE Copied 9 times
Technology Ownership. Employee hereby assigns to the Company all inventions, discoveries, designs, trade secrets, formulae, processes, methods, techniques, mask works, improvements, developments, concepts, computer programs, databases and works which Employee may make or acquire during the term of his/her employment hereunder, whether or not during working hours and whether made solely or jointly with others, that (1) are related to the Business of the Company at the time they are made or acquired, or (2) are made using the equipment, supplies, facilities, or proprietary information of the Company, as well as all patents, patent applications, copyrights, copyright registrations and all other intellectual property rights which cover, protect or are embodied in any of the foregoing.
Technology Ownership. Alkermes retains the sole right, title and interest, subject only to the license granted in Sections 3.8 of this Agreement, to the Alkermes Know-How. Except as expressly provided in this Agreement, no rights in any other technology, intellectual property or assets of Alkermes are granted to Corregidor by implication, estoppel or otherwise.
Technology Ownership. 33 10.2 CONTRIBUTED PRODUCT LICENSES; SUBLICENSE RIGHTS ............... 34 10.3 COLLABORATION PRODUCT LICENSE; SUBLICENSE RIGHTS .............. 34 10.4 PASS THROUGH RESTRICTIONS ..................................... 35 10.5
Technology Ownership. 5.1.1 As between the Parties, [*] shall own all right, title and interest in and to all [*] Technologies, subject to the rights and licenses granted to Amgen hereunder.
5.1.2 Other than as expressly set forth in this Licence Agreement, neither Party shall have any right in and to any intellectual property owned or controlled by the other Party and neither Party shall have an obligation to grant the other Party any rights therein.
5.1.3 Other than as expressly set forth in Articles 5.2, 5.3 and 5.4, neither Party shall have the right to prepare, file, prosecute, maintain, defend, settle and/or enforce Patent Rights or Trademarks Controlled by the other Party, such activity being the exclusive right (but not the obligation) of the Party Controlling the same.
Technology Ownership. Nissan and its Service Providers are and shall at all times be the owner of all right, title and interest in and to (i) any and all hardware, software and related technology, used by Nissan as a part of or in conjunction with the NissanConnect Services, and (ii) all intellectual and other proprietary rights, including without limitation all patent, copyright, trademark and trade secret rights contained therein. It is prohibited to, and you agree that you shall not, copy, decompile, disassemble, reverse engineer, make derivative works of or manipulate any technology or data or content stored or incorporated in any equipment used to receive or operate the NissanConnect Services (collectively,
Technology Ownership. Except as otherwise provided below in this Agreement, ownership of inventions shall be determined in accordance with the rules of inventorship under [**] Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed with the Commission. United States patent laws. Amgen shall own all right, title and interest in and to Amgen Technology, and any Confidential Information contained therein shall be considered the Confidential Information of Amgen. ViaCell shall own all right, title and interest in and to ViaCell Technology, and any Confidential Information contained therein shall be considered the Confidential Information of ViaCell. All right, title and interest in and to Joint Know-How (which shall be considered the joint Confidential Information of the Parties) and Joint Patent Rights shall be owned, as between the Parties, jointly by ViaCell and Amgen. Each Party shall have the unrestricted, royalty-free, worldwide right to make, have made, use, sell, lease, offer to sell or lease, import, export or otherwise exploit, or transfer physical possession of or title in Joint Know-How and the subject matter of the Joint Patent Rights, without accounting. All rights, title and interest in and to Product Trademarks shall be owned by Amgen.
Technology Ownership. All Technology resulting from the Research and Development Projects (“Solazyme Project Technology”) whether made by a JV Company or a member of the Solazyme Group, or jointly by a JV Company, on the one hand, and a member of the Solazyme Group, on the other hand, shall be owned, as among the JV Companies and the Solazyme Group, by Solazyme, Inc., but shall be subject to the licenses provided in Article 6.
Technology Ownership. All technology necessary for the conduct of research in the Agreement Field pursuant to the Research Program shall be licensed by the respective parties to each other on a royalty-free basis throughout the term of the R&D Collaboration. The license is limited to enabling the research to be conducted pursuant to the R&D Collaboration.
Technology Ownership. Both Parties acknowledge and agree that Arena has and shall retain at all times exclusive ownership of Arena Technology, and that Lilly has and shall retain at all times exclusive ownership of Lilly Technology, including CART Identified Compound(s) and Drug Product(s).
Technology Ownership. Unless otherwise specifically agreed, each PARTY shall retain ownership of its BACKGROUND INTELLECTUAL PROPERTY. The PARTIES shall agree, in writing, on the level of funding and ownership of FOREGROUND INTELLECTUAL PROPERTY developed under the MTDA.